Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Evidences from J-EDIT for diabetes mellitus in the elderly].

Ito H.

Nihon Rinsho. 2013 Nov;71(11):1923-31. Review. Japanese.

PMID:
24397160
2.
3.

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.

4.

Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.

Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H; Japanese Elderly Diabetes Intervention Trial Research Group.

Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:88-102. doi: 10.1111/j.1447-0594.2011.00816.x.

PMID:
22435944
5.

[Stroke in the elderly people with diabetes mellitus].

Minagawa S, Hanyu O, Sone H.

Nihon Rinsho. 2013 Nov;71(11):1948-53. Japanese.

PMID:
24397164
6.

Efficacy of lifestyle interventions in patients with type 2 diabetes: A systematic review and meta-analysis.

Huang XL, Pan JH, Chen D, Chen J, Chen F, Hu TT.

Eur J Intern Med. 2016 Jan;27:37-47. doi: 10.1016/j.ejim.2015.11.016. Epub 2015 Dec 3. Review.

PMID:
26655787
8.

Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients.

Araki A, Iimuro S, Sakurai T, Umegaki H, Iijima K, Nakano H, Oba K, Yokono K, Sone H, Yamada N, Ako J, Kozaki K, Miura H, Kashiwagi A, Kikkawa R, Yoshimura Y, Nakano T, Ohashi Y, Ito H; Japanese Elderly Intervention Trial Research Group.

Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:18-28. doi: 10.1111/j.1447-0594.2011.00809.x.

PMID:
22435937
9.

Sex differences in the effect of HbA1c-deļ¬ned diabetes on a wide range of cardiovascular disease risk factors.

Du T, Yuan G, Zhou X, Sun X.

Ann Med. 2016;48(1-2):34-41. doi: 10.3109/07853890.2015.1127406. Epub 2016 Jan 13.

10.

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.

PMID:
17420118
11.

[Dyslipidemia in diabetes mellitus].

Niemeijer-Kanters SD, Banga JD, Erkelens DW.

Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):769-74. Review. Dutch.

PMID:
11346913
12.

High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.

Gonzalez GL, Manrique CM, Sowers JR.

J Cardiometab Syndr. 2006 Summer;1(3):178-83. Review.

13.
14.

Is the Proportion of Carbohydrate Intake Associated with the Incidence of Diabetes Complications?-An Analysis of the Japan Diabetes Complications Study.

Horikawa C, Yoshimura Y, Kamada C, Tanaka S, Tanaka S, Matsunaga S, Hanyu O, Araki A, Ito H, Tanaka A, Ohashi Y, Akanuma Y, Sone H.

Nutrients. 2017 Feb 6;9(2). pii: E113. doi: 10.3390/nu9020113.

15.

Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA study.

Sone H, Nakagami T, Nishimura R, Tajima N; MEGA Study Group.

Diabetes Res Clin Pract. 2016 Mar;113:14-22. doi: 10.1016/j.diabres.2015.12.002. Epub 2016 Jan 18.

16.

Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?

Reddy SV, Bhatia E.

Natl Med J India. 2011 Jan-Feb;24(1):21-7. Review.

PMID:
21608354
18.

Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.

Nichols GA, Joshua-Gotlib S, Parasuraman S.

J Gen Intern Med. 2013 May;28(5):691-7. doi: 10.1007/s11606-012-2320-1. Epub 2013 Jan 24.

19.

Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia.

Falko JM, Moser RJ, Meis SB, Caulin-Glaser T.

Curr Diabetes Rev. 2005 May;1(2):127-35. Review.

PMID:
18220588
20.

A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial.

Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, Yancy WS Jr, Brinkworth GD.

Diabetes Care. 2014 Nov;37(11):2909-18. doi: 10.2337/dc14-0845. Epub 2014 Jul 28.

PMID:
25071075

Supplemental Content

Support Center